Nektar Therapeutics (NASDAQ:NKTR)

4.00
Delayed Data
As of Jun 24
 -0.16 / -3.85%
Today’s Change
3.02
Today|||52-Week Range
19.37
-70.39%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close4.16
Today’s open4.21
Day’s range3.98 - 4.26
Volume781,625
Average volume (3 months)3,908,458
Market cap$745.1M
Data as of 5:17pm ET, 06/24/2022

Growth & Valuation

Earnings growth (last year)-14.83%
Earnings growth (this year)+19.25%
Earnings growth (next 5 years)+8.74%
Revenue growth (last year)-33.36%
P/E ratioNM
Price/Sales24.30
Price/Book1.09

Competitors

----
SRNESorrento Therapeutic...-0.21-9.43%
COGTCogent Biosciences I...-0.47-4.83%
ATRAAtara Biotherapeutic...-0.04-0.54%
Data as of 4:01pm ET, 06/24/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$101.9M
Annual profit (last year)-$523.8M
Net profit margin-514.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Francisco, California

Forecasts